ArticleHeliyon2024
Early heart disease prediction using feature engineering and machine learning algorithms.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Explainable and High-Performance ECG-Informed Machine Learning and Deep Learning Framework for Cardiovascular Risk Prediction.Life (Basel, Switzerland) · 2026Article
- CardioMetaHybridOptimizer as a behaviorally adaptive multi-phase metaheuristic framework for interpretable cardiovascular disease diagnosis.BMC bioinformatics · 2026Article
- Comparative performance of machine learning and deep learning models for heart disease prediction in a small clinical dataset.American journal of cardiovascular disease · 2026Article
- SGO enhanced random forest and extreme gradient boosting framework for heart disease prediction.Scientific reports · 2025Article
- Development and validation of a machine learning approach for screening new leprosy cases based on the leprosy suspicion questionnaire.Scientific reports · 2025Article
- A systematic review of machine learning in heart disease prediction.Turkish journal of biology = Turk biyoloji dergisi · 2025Review
- From data to decision: an interpretable machine learning model for optimizing RAI therapy in Graves' hyperthyroidism.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart disease is one of the most widespread global health issues, it is the reason behind around 32 % of deaths worldwide every year. The early prediction and diagnosis of heart diseases are critical for effective treatment and sickness management. Despite the efforts of healthcare professionals, cardiovascular surgeons and cardiologists' misdiagnosis and misinterpretation of test results may happen every day. This study addresses the growing global health challenge raised by Cardiovascular Diseases (CVDs), which account for 32 % of all deaths worldwide, according to the World Health Organization (WHO). With the progress of Machine Learning (ML) and Deep Learning (DL) techniques as part of Artificial Intelligence (AI), these technologies have become crucial for predicting and diagnosing CVDs. This research aims to develop an ML system for the early prediction of cardiovascular diseases by choosing one of the powerful existing ML algorithms after a deep comparative analysis of several. To achieve this work, the Cleveland and Statlog heart datasets from international platforms are used in this study to evaluate and validate the system's performance. The Cleveland dataset is categorized and used to train various ML algorithms, including decision tree, random forest, support vector machine, logistic regression, adaptive boosting, and K-nearest neighbors. The performance of each algorithm is assessed based on accuracy, precision, recall, F1 score, and the Area Under the Curve metrics. Hyperparameter tuning approaches have been employed to find the best hyperparameters that reflect the optimal performance of the used algorithms based on different evaluation approaches including 10-fold cross-validation with a 95 % confidence interval. The study's findings highlight the potential of ML in improving the early prediction and diagnosis of cardiovascular diseases. By comparing and analyzing the performance of the applied algorithms on both the Cleveland and Statlog heart datasets, this research contributes to the advancement of ML techniques in the medical field. The developed ML system offers a valuable tool for healthcare professionals in the early prediction and diagnosis of cardiovascular diseases, with implications for the prediction and diagnosis of other diseases as well.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.